Skip to main content
. 2021 Sep 27;12:722807. doi: 10.3389/fimmu.2021.722807

Figure 2.

Figure 2

Association of PLOD3 expression with clinicopathological characteristics, including (A) CRC N stage, (B) CRC M stage, (C) CRC pathologic stage, (D) MSI and MSS, and (E) overall survival (OS). *p < 0.05, ***p < 0.001, ns, No Significance.